Medicare Will Pay for Prostate Cancer Drug – New York Times (blog)
 Forbes (blog) |
Medicare Will Pay for Prostate Cancer Drug
New York Times (blog) By ANDREW POLLACK Medicare confirmed Thursday that it would pay for Provenge, the prostate cancer drug whose $ 93000 price had sparked debate about the cost of cancer treatments. The Centers for Medicare & Medicaid Services said in a final decision … Medicare confirms payment for prostate cancer drug Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer Drug FDA Clears Dendreon 2nd Facility |
Short URL: http://trends-medical.com/?p=305
Posted by admin
on Jun 30 2011. Filed under DRUGS & SUPPLEMENTS.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.